Navigation Links
Hormone replacement therapy linked to increased lung cancer risk
Date:3/3/2010

PORTLAND, Ore. Women aged 50 to 76 who take estrogen plus progestin may have an increased risk of lung cancer, according to a new study published in the pre-print online edition of the Journal of Clinical Oncology.

Although the risk is "duration-dependent," with women taking HRT for 10-plus years at greatest risk of developing lung cancer, an acceptable length of HRT has yet to be determined, the researchers report.

While the risk of developing lung cancer for women using estrogen plus progestin HRT 10 years or longer was approximately 50 percent more than women not using HRT, this risk is actually quite small compared to the risk from smoking.

"Although HRT use has declined and is not recommended except for short-term treatment of menopausal symptoms, our results indicate millions of women may remain at risk of developing lung cancer," said Chris Slatore, M.D., principal investigator and an assistant professor of medicine (pulmonary and critical care medicine) in the Oregon Health & Science University School of Medicine, Portland Veterans Affairs Medical Center; and a member of the OHSU Knight Cancer Institute.

To conduct this research, Slatore and colleagues reviewed data collected from 2000 to 2002 in the Vitamins and Lifestyle Study in Washington state. They identified 36,588 peri- and postmenopausal participants aged 50 to 76 who met their study criteria and followed them for six years using the Seattle-Puget Sound Surveillance, Epidemiology and End Results cancer registry.

At the end of the observation period, December 31, 2007, 344 of the participants had developed lung cancer. After adjusting for smoking, age and other factors that affect the risk of lung cancer, the researchers determined the use of estrogen and progestin for 10 or more years was associated with increased risk for lung cancer compared with no use of HRT. They also found duration of use was associated with an advanced stage of cancer at diagnosis.

Although the mechanisms underlying the association between HRT and lung cancer are still unknown, the researchers report that genetic and environment interactions likely play a role. They also suggest that estrogen plus progestin may lead to more aggressive disease or mask early symptoms, or HRT users may be less likely to see or receive medical care in a timely fashion.

"These findings may be useful in counseling women about their risk of developing lung cancer and prompt further research into the mechanisms underlying HRT and increased lung cancer risk," said Slatore.


'/>"/>

Contact: Tamara Hargens-Bradley
hargenst@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Related medicine news :

1. High Hormone Level Linked to Cancer Death in Older Men
2. Hormone Outperforms Insulin in Diabetic Mice
3. Hormone thought to slow aging associated with increased risk of cancer death
4. Buy HGH Website Educates Consumers on the Pros and Cons of Human Growth Hormone Supplements
5. Stress hormone, depression trigger obesity in girls
6. Testicular Cancer Survivors May Have Hormone Deficiency
7. Early On, Hormone Therapy May Raise Womens Heart Risks
8. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
9. Bonding Hormone Might Help Some With Autism
10. Hormone May Prevent Aggressive Breast Cancer
11. Pioneering Hormone Therapist to Host Free Health Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips may ... to popular cosmetic improvement efforts. Record numbers of clients now ask about lip plumping ... pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The trend ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In 1980, ... running plumbing calls throughout the beach community. His vision to grow the company was ... and ensuring they maintain the highest level of training and customer service. Over 35 ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... weekend to host their second pop-up shop for three consecutive weekends. The pop-up ... to the Santa Barbara community, a community full of women who appreciate the ...
(Date:5/25/2016)... ... 26, 2016 , ... The 12th session of the Silicon Valley BioTalks will ... Palo Alto, CA. This Bay Area biotech event will focus on “Setting Up Early ... the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization (CRO) Experien Group, and Electronic ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Furthering its ... amateur athletics, The National Center for Drug Free Sport (Drug Free Sport®) is excited ... This conference, to be held July 12 – 13 in Kansas City, MO, will ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- Global Paclitaxel Market 2016 Industry Research ... and the Paclitaxel analysis in this study is supported ... its players. This is the latest Paclitaxel ... current state of the industry while providing a basic ... industry chain structure. The Paclitaxel market analysis is provided ...
(Date:5/23/2016)... 2016 According to market ... Growth and Demand Forecast to 2022 - Industry ... Application (Drug Discovery and Development, Proteomics, Clinical Testing, ... Science and Biotechnology, Academic and Research Institute, Hospitals ... global mass spectrometry market was valued ...
(Date:5/23/2016)... JERUSALEM , May 23, 2016 ... DNA for detection of multiple diseases; ,Technology to be ... Yissum Research Development Company of the ... entered into a research agreement with Aurum Ventures MKI, the ... the development of a new diagnostic approach for early ...
Breaking Medicine Technology: